Saturday, April 19, 2025
28.8 C
Bengaluru

Generics Only

[wpfilebase tag=file id=90 tpl=download-button /]

Inside this Issue

1. GUEST EDITORIAL: Generics Only – Does the Patient Benefit? by K. Hariram
How much will patients benefit from a regulation that only allows Doctors to prescribe generics?

2. Dinesh Thakur Tackles the Branded v. Generics Debate by Dinesh Thakur
This article features excerpts of a series of blogs written by well-know healthcare entrepreneur, activist and commentator, Dinesh Thakur, on the recent branded v. generics debate.

3. Quality, Not Price, is the Key Issue When Prescribing Generic Drugs in India by Anup Soans
In the absence of a standard drug regulatory mechanism, Indian doctors rely on the reputation of companies who have demonstrated their commitment to quality over time.

Hot this week

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

Rx 2024 – Top 25 Drugs by Sales, Growth & Market Trends

The pharmaceutical market in 2024 saw major shifts driven...

India’s Medical Devices Market: Strategic Implications and Key Investors

KKR's Investments in India's Medical Devices Market: Strategic Implications...

Topics

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

Rx 2024 – Top 25 Drugs by Sales, Growth & Market Trends

The pharmaceutical market in 2024 saw major shifts driven...

India’s Medical Devices Market: Strategic Implications and Key Investors

KKR's Investments in India's Medical Devices Market: Strategic Implications...

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...
spot_img

Related Articles

spot_imgspot_img